Oxford BioMedica plc Stock London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 * | 90.48M 113M | Sales 2024 * | 130M 162M | Capitalization | 205M 255M |
---|---|---|---|---|---|
Net income 2023 * | -89M -111M | Net income 2024 * | -38M -47.26M | EV / Sales 2023 * | 1.72 x |
Net cash position 2023 * | 49.23M 61.23M | Net cash position 2024 * | 15.51M 19.28M | EV / Sales 2024 * | 1.46 x |
P/E ratio 2023 * |
-2.25
x | P/E ratio 2024 * |
-5.33
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 23-03-26 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 17-08-28 |
Chairman | 68 | 20-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 23-04-30 |
Chairman | 68 | 20-06-23 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 16-05-31 |
1st Jan change | Capi. | |
---|---|---|
-2.76% | 102B | |
+1.86% | 96.07B | |
-1.72% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-40.31% | 16.91B | |
-27.56% | 13.79B | |
+0.27% | 13.33B | |
+21.11% | 10.94B |